RUNX2 promotes the attraction and adhesion of breast cancer cells to the bone and confers cancer cell survival and bone colonization advantages in mice through its transcriptional target integrin α5, establishing integrin α5 as a potential target for preventing bone colonization [35]. Here, RUNX2 is linked to breast carcinoma.